Molecular Formula: C14H24N6O4Cu
Participants will be randomized to one of three groups: two groups will receive different doses of survodutide, and the other group will receive a placebo injection
The aetiology of HS is complex and multifactorial, involving genetic predisposition, environmental triggers like smoking, and significant systemic comorbidities, including metabolic, cardiovascular, musculoskeletal, gastrointestinal, and mood disorders
Indeed, in the cardiovascular outcome trial (CVOT) for semaglutide, SUSTAIN 6 a relatively short (two-year) and small (3,297 individuals) preregistration trial (an extensive CVOT in obese individuals without T2DM (SELECT) is expected to complete in 2024) HbA 1c was powerfully and durably reduced
Consult your doctor: Before starting any weight loss medication, its crucial to consult with a healthcare professional to assess your individual needs and risks